Deoxycytidine kinase (dCK) phosphorylates 2'-deoxycytidine, as well as the purine deoxyribonucleosides and a number of nucleoside analogues that are important in the chemotherapy of leukemias. The enzyme is highly expressed in the thymus relative to other tissues and may play an important role in the T cell depletion associated with adenosine deaminase and purine nucleoside phosphorylase deficiencies. To characterize the dCK promoter region and to determine whether it mediates higher levels of gene expression in T lymphoblasts, we have analyzed a 700-bp genomic fragment encompassing 548 bp of 5' flanking region for functional activity and for transcription factor binding using T and B lymphoblast cell lines and nuclear extracts. The regions of the promoter that were defined as important to its function include a 5'GC box, an E box, a 3'GC box, and an E2F site. The transcription factor Spl binds to both GC boxes, activating at the 5' site but repressing at the 3' site. MLTF/ USF activates transcription through the E box, whereas E2F activates through the E2F site, but binds weakly to this site in vitro and does not appear to mediate cell cycle-specific expression of dCK in vivo. No significant differences in promoter activity or transcription factor binding were observed between Jurkat T and Raji B lymphoblasts. The promoter of the dCK gene is thus regulated by a number of ubiquitously expressed transcription factors. DCK expression in cultured lymphoblast cell lines is not solely a function of the T or B lineage derivation. (J. Clin. Invest. 1995. '95:1660-1668 
Introduction
Deoxycytidine kinase (NTP:deoxycytidine 5 '-phosphotransferase, EC 2.7.1.74; dCK)' catalyzes the phosphorylation of 2'-1. Abbreviations used in this paper: ADA, adenosine deaminase; bHLH, basic helix-loop-helix; CdA, 2-chlorodeoxyadenosine; dCK, deoxycytidine kinase; DHFR, dihydrofolate reductase; SSP, stage selector protein; TK, thymidine kinase; CAT, chloramphenicol acetyltransferase; CMV, cytomegalovirus; RSV, Rous sarcoma virus.
deoxycytidine to its 5'-monophosphate and, despite a much higher Km for the purine deoxyribonucleosides, also plays a major role in phosphorylating 2 '-deoxyadenosine and 2 '-deoxyguanosine to their corresponding monophosphates (1) (2) (3) (4) . dCK is also central in the activation of anticancer and antiviral agents such as cytosine arabinoside, fludarabine, 2 ',3 '-dideoxycytidine, and 2-chlorodeoxyadenosine (CdA) (5) (6) (7) (8) (9) . Cell lines lacking dCK activity are resistant to these nucleoside analogues (10) , whereas increased dCK activity has been associated with increased sensitivity to these agents ( 11) .
dCK also may play an important role in the pathogenesis of the immunodeficiency syndromes associated with deficiencies of the purine catabolic enzymes adenosine deaminase (ADA) and purine nucleoside phosphorylase ( 12) . The preferential cytotoxicity of the ADA substrate, 2'-deoxyadenosine, and the purine nucleoside phosphorylase substrate, 2'-deoxyguanosine, for human thymocytes has been thought to account for the T cell depletion in these disorders. Cytotoxicity has been attributed to the ability of thymocytes and human T lymphoblasts to accumulate the corresponding 2'-deoxyribonucleoside triphosphates from these substrates, resulting in inhibition of DNA synthesis. Deoxyribonucleotide accumulation in turn has been felt to result from the relatively high levels of dCK and the low levels of 5 '-nucleotidase in these cells. Several studies have demonstrated higher levels of dCK activity (13) (14) (15) and mRNA (16) in human thymocytes and T lymphoblasts than in other tissues, including EBV-immortalized B lymphoblasts, although normal peripheral blood T and B cells appear to contain similar amounts of dCK activity and immunoreactive protein (17) .
To understand the molecular basis for tissue-specific regulation of dCK activity in normal and neoplastic human cells, we have cloned the dCK gene and identified its promoter (18) . The 5 ' region of the gene is highly GC rich and lacks TATA or CAAT boxes. It does have an E2F site similar to those found in the promoters of dihydrofolate reductase (DHFR), thymidine kinase (TK), c-myc, and other genes important for the initiation of DNA synthesis (19, 20) . Preliminary transfection experiments into transformed human T and B lymphoblast cell lines revealed significantly higher levels of expression of this promoter in T lymphoblasts. Since the regulation of expression of this gene may directly relate to the chemosensitivity of neoplastic cells to certain nucleoside analogs, we have further defined the mechanisms responsible for its regulation in cultured lymphoblast cell lines.
Methods
Deletion mutants. A 700-bp HindHII fragment spanning the promoter, first exon, and 61 bp of the first intron was cloned into pCAT-Basic (Promega, Madison, WI) to yield pCAT-Basic 700 (see Fig. 2 ). Digestion of this construct with SmaI resulted in the removal of 183 bp of 5' sequence (pCAT-Basic 517). Removal of the first intron segment, first exon, and most of the 5' untranslated region from pCAT-Basic cloned into pUC CAT to take advantage of the Sacd and SmaI sites in the multiple cloning site. Deletions were made from the 5' end after digestion with Sacd and SmaI to create exonuclease-resistant and susceptible ends, respectively, using an Exo III/Mung bean nuclease deletion kit from Stratagene (La Jolla, CA). All deletion mutant plasmids were prepared using Qiagen columns (Chatsworth, CA) and sequenced by the dideoxy chain termination method (USB, Cleveland, OH).
Transfections. Jurkat T lymphoblasts and Raji B lymphoblasts were grown in RPMI and 10% FCS. Cells were harvested during exponential growth, washed in serum-free medium, and resuspended at 107 cells per 400 y1 of RPMI. CAT plasmids (30 jug) and cytomegalovirus (CMV)-lacZ or fi-actin-lacZ plasmids (courtesy of Lorraine Gudas, Cornell University, NY) (10-30 dIg) were resuspended in 100 Il of PBS and mixed with the cells. Electroporation was performed with a Gene Pulser (Bio-Rad Laboratories, Richmond, CA) with 0.4-cm cuvettes at 250 V, 960 HF. Cells were harvested after 48 h, and extracts were prepared by three freeze-thaw cycles and removal of insoluble debris by centrifugation. For chloramphenicol acetyltransferase (CAT) assays, 5-50-k1 aliquots of heated cell extracts (21) were assayed with 0.1 I Ci of ['4C]chloramphenicol and 25 pg of n-butyryl CoA in 125 ILI. Reactions were stopped with xylenes, and the reaction products were extracted and counted (22). ,B-Galactosidase activity was measured in unheated extracts using chlorophenol red /3-D-galactopyranoside as a substrate (23) .
Nuclear extracts. Extracts were made from exponentially growing Jurkat and Raji cells by the method of Dignam et al. (24) with modifications as described by Blake et al. (25) . Cells were homogenized in buffer A (10 mM Hepes, pH 7.9, 0.75 mM spermidine, 0.15 m.M spermine, 0.1 mM EDTA, 0.1 mM EGTA, 10 mM KCl, 1 mM DTT, 1 mM PMSF), and nuclei were sedimented by centrifugation at 30,000 g for 30 s. Nuclear factors were then extracted in buffer C (20 mM Hepes, pH 7.9, 0.2 mM EDTA, 0.2 mM EGTA, 2 mM DTT, 20% glycerol, 0.15 mM spermine, 0.75 mM spermidine, 1 m.M PMSF, 0.4 M NaCl). The extract was subjected to centrifugation for 45 min at 300,000 g, followed by dialysis in modified buffer D (20 mM Hepes, pH 7.9, 20% glycerol, 100 mM KCl, 0.2 mM EDTA, 0.2 mM EGTA, 2 mM DTT, 1 mM PMSF, 12.5 mM MgCl2). The extracts were aliquoted and stored at -700C.
DNase Ifootprinting. Three probes were prepared to span the region from -450 to + 151 (relative to the translation start site) of the dCK promoter. The first probe was prepared by digesting the 700-bp promoter with PstI, end labeling with Klenow (taking advantage of its 3' -5' exonuclease activity), and digesting with BglI, yielding a 254-bp probe spanning -450 to -197. A second probe was prepared by digesting the promoter with NarI, incubating with calf intestinal alkaline phosphatase, and labeling the ends with T4 polynucleotide kinase or Klenow. This labeled DNA was then cut with MaelH, yielding a 217-bp probe spanning -299 to -83. A third probe was prepared by digesting the promoter with HindIl, labeling with Klenow, and digesting with CfrlOI. This last 291-bp probe spanned the region between -140 and + 151. Probes were electrophoresed on nondenaturing polyacrylamide gels and eluted by the "crush and soak" method (26) . DNase footprinting was performed according to Blake et al. (25) . 5-10 ng of end-labeled DNA was incubated with nuclear extract in the presence of 15 yg of poly (dldC) in a 120-,lI volume containing 6.1% glycerol, 0.07 mM EDTA, 0.07 mM EGTA, 7.2 mM Hepes, pH 7.9, 39 mM KCl, 7.5 mM MgCI2, and 0.7 mM DTT. The binding reaction mixtures were incubated on ice (for kinase-labeled probes) or at room temperature for 30 min. CaCI2 (2 mM final concentration) was added, and protein-DNA complexes were digested with DNase I (Worthington Enzymes, Freehold, NJ) for 4 min at room temperature. Purified Spl was purchased from Promega, and footprinting reactions were done according to the Promega protocol. Digestions were stopped by adding 2 vol of a mix containing 100 mM Tris, pH 8, 20 mM EDTA, 0.1% SDS, 100 yg/ml proteinase K, and 100 ILg/ml glycogen. After incubation at 37°C for 20 min, the samples were extracted with phenol-chloroform and precipitated with ethanol. Samples were resuspended in formamide loading dye and run on 6% sequencing gels.
Site-directed mutagenesis. Mutagenesis of the promoter was accomplished by the method of Kunkel et al. (27) with the 3 'GC-M, oligonucleotide, or by recombinant PCR (28) . Sense-strand mutagenic primers are shown below, with the consensus transcription factor-binding sites underlined and the mutated bases shown in lowercase:
Oligonucleotidesubstitutions were designed as reported previously (25, (29) (30) (31) , or were shown not to bind the relevant transcription factor by gel-shift assays. 7-Deaza-dGTP (1:1 with dGTP) was used to amplify the GC-rich promoter, and Pfu DNA polymerase (Stratagene) was used to maximize fidelity of DNA synthesis. Promoter fragments containing the designated substitutions were cloned into pCAT-Basic at the SalI site. All plasmids were prepared using Qiagen columns and sequenced. Gel-shift assays. The sequences of the wild-type sense oligonucleotides are shown below, with the consensus transcription factor-binding sites underlined: 5 (33) . Incubations were allowed to go for 20 min at room temperature. If competitor oligonucleotides were used, they were allowed to preincubate on ice for 10 min before addition of the probe. With antibodies, the preincubation time was 2-4 h on ice. With purified Spl, 10 ,ug of BSA was included in the incubation. Anti-Sp1 antibody was purchased from Santa Cruz Biotechnology (Santa Cruz, CA), and anti-USF was provided by Robert Roeder (The Rockefeller University, New York). Binding reactions were resolved on 4% (30:1 acrylamide/bis) nondenaturing Tris-glycine-2.5% glycerol or 0.5x Tris-borate-EDTA minigels.
Gels were run at 100 V, dried, and autoradiographed. Nuclear run-on assays. Single-stranded probes for portions of exon 1 (322 bases), intron 2 (400 bases), and exon 6 (422 bases) were prepared by cloning into M13mpl 8 or M13mpl9. All other probes were prepared from cDNAs in double-stranded plasmids. Cells (5 x 107) in exponential growth were harvested, washed in PBS, resuspension buffer (10 mM Tris, pH 7.4, 10 mM NaCl, 5 mM MgCl2), and resuspension buffer + 0.5% NP-40. Nuclei were then resuspended in 210 p1 of nuclear freezing buffer (50 mM Tris, pH 8. 
Results
We demonstrated previously that a 700-bp HindII fragment from the dCK gene possesses promoter activity upon transfection into human lymphoblast cell lines, with 12-19-fold higher activity in Jurkat T lymphoblasts than in Raji B lymphoblasts after normalizing for transfection efficiency with cotransfection of CMV-or Rous sarcoma virus (RSV)-IacZ (18) . Fig. 1 shows the sequence of this fragment, corrected with the addition of 3 bases at -292, -144, and -140. To delineate basal elements and to explore possible cell-specific elements in the promoter, we analyzed a series of deletion mutants for promoter activity (Fig. 2) . Deletion of 183 bp of 5' sequence (pCATBasic 517) increased promoter activity by two-to threefold. Deletion of 273 bp from the 3' end removed much of the 5' untranslated sequence, the first exon, and the first intron segment (pCAT-Basic 244). This fragment produced 20 (Fig. 3 A) , the region that encompasses the 5 'GC box and the E box. A second protected region was observed from -221 to -197, corresponding to the 3'GC box. This footprint was also detected using the probe from -299 to -83 (Fig. 3 B) . The Promoter Activity (% of 244-bp core) hypersensitive sites were clearly observed on either side of the E2F site with DNase I digestion (Fig. 3 B) . Similar resistance to DNase I cleavage has also been observed at the E2F site of the hamster DHFR gene (29) . No sites of protection from or hypersensitivity to DNase I digestion were detected in the region from -140 to + 151 (data not shown). DNase I footprints were identical using either Jurkat or Raji nuclear extracts. The functional significance of the protected regions was evaluated by in vitro mutagenesis and transfection analysis. Four regions were independently mutated: the 5'GC box, E box, 3 'GC box, and E2F site. As shown in Fig. 4 , mutation of the 5 'GC box reduced CAT activity by 50-70% relative to the wild-type 244-bp promoter. Mutation of the E box decreased CAT activity by 50%. In our E box mutant, we mutated CACGTG to CACGAC to prevent basic helix-loop-helix (bHLH) transcription factors from binding (31 ) . This mutation inadvertently created a new E box, CACGACACCTG, but the consistent reduction in CAT activity strongly suggests that it cannot substitute for the native site. A 5-bp substitution of the 3 'GC box (MI) caused an unexpected increase in CAT expression that was more modest in Jurkat cells (150% of wild type) than in Raji cells (250% of wild type). To confirm this result, we changed and extended the mutation at this site by replacing 10 bases (3 'GC-M3). CAT activity remained consistently above that of the 244-bp native promoter (200-270%). Mutation at the E2F site reduced promoter activity by 30-60%, suggesting a functional role for this region.
Gel-shift analysis was performed to identify the specific transcription factor(s) binding to these regions. The 5 'GC and E boxes were included in one oligonucleotide probe. Incubation of this probe with either Jurkat or Raji nuclear extracts yielded three bands (Fig. 5 A) . The top and bottom bands were competed by an unlabeled 22-bp oligonucleotide with a perfect SpI consensus sequence, a result consistent with the known doublet pattern of Spl in gel-shift assays (30) . The middle band was competed by an oligonucleotide containing the CACGTG sequence from the adenovirus major late promoter. Although the S 'GC box and the E box formed one extended footprint, these gel-shift results suggest that SpI and USF do not bind cooperatively; no conclusions can be made about competitive interactions. Antibody to SpI supershifted the SpI complexes, whereas anti-USF antibody prevented protein binding to the E box. Spl also bound to the 3'GC box (Fig. S B) with the expected competition and antibody supershift patterns. When the E2F site of the dCK promoter was used in a gel-shift assay, no shifted bands were apparent (data not shown). Using the same conditions, a 29-bp dyad E2F site from the hamster DHFR promoter did shift (Fig. 5 C) . The Since no significant differences were observed in dCK promoter activity or protein binding between Jurkat and Raji cells, we performed nuclear run-on transcription assays to measure directly the relative levels of dCK transcription in these cells (Fig. 6 A) . Exon CAT activities were normalized to P-galactosidase activities and are represented as a percentage of the wild-type 244-bp promoter. Bars represent mean±SD of two separate experiments done in duplicate. (13, 15) , it was unclear whether T cells had more activity than B cells. Early studies demonstrated that thymocytes and T lymphoblasts were more sensitive to 2'-deoxyadenosine and 2'-deoxyguanosine toxicity than B lymphoblasts (37, 38) . It was postulated that high levels of dCK activity, coupled with low cytoplasmic 5'-nucleotidase or other catabolic activity, trapped purine deoxyribonucleotides intracellularly (13) . The accumulation of these purine deoxyribonucleotides could then result in cytotoxicity by a variety of possible mechanisms, including inhibition of ribonucleotide reductase, DNA nicking and subsequent depletion of nicotinamide adenine dinucleotide, ATP depletion, or inhibition of transmethylation reactions ( 12) . The literature on T versus B cell dCK activity is somewhat contradictory, and interpretation of the results is dependent on a critical examination of how the assays were done and which cells were used. dCK activity is regulated by dCTP, ADP, and other metabolites (4); furthermore, several other enzymes such as cytidine deaminase, 5 '-nucleotidase, phosphatases, and thymidine kinase 2 greatly influence product formation (15) . Although thymic lymphocytes have high dCK activity, activities in other lymphocyte populations vary. Tonsillar, splenic, and peripheral blood T and B lymphocytes in particular have lower dCK activities (39) (40) (41) . If cultured cell lines are used, malignant transformation and extent of differentiation must be considered in addition to lineage (42). Our earlier studies demonstrated both 5-10-fold higher levels of dCK mRNA in MOLT-4 and Jurkat T lymphoblasts than in EBV-immortalized B lymphoblasts (16) and many-fold higher levels of CAT activity when the dCK promoter-CAT construct was transfected into Jurkat T as compared with Raji B lymphoblasts (18) . The use of the Raji cells in the latter experiments was dictated by their high degree of transfectability. We now believe this difference in dCK reporter gene activity to be an artifact for the following reasons: (i) all dCK promoter deletion mutants, as well as the promoterless pCAT-Basic vector, expressed much more CAT enzyme in Jurkat than in Raji cells; (ii) Raji cells have 30-40% more dCK mRNA than Jurkat cells, as determined by Northern analysis; and (iii) nuclear runon assays demonstrated that transcription of the exon 1 region of the gene is proportional to steady-state mRNA levels in both cell lines. Of note here is the marked disparity between Raji B lymphoblasts and EBV-immortalized B lymphoblasts from normal individuals. The Raji cell line was derived from a Burkitt's lymphoma (43) and has undergone malignant transformation. In contrast, the EBV-infected cells have been immortalized, but are not neoplastic. It is of interest that the Raji B lymphoblasts are akin to T lymphoblasts in their sensitivity to deoxyadenosine and their ability to accumulate purine deoxyribonucleotides (42, 44) . Whether or not these features result from differences in dCK expression remains uncertain. These data do emphasize the difficulty in extrapolating from cultured cell lines to normal lymphocytes at different stages of development.
We have analyzed the 700-bp promoter of the dCK gene in detail. Four elements in the dCK promoter appear to be of major importance in mediating gene transcription. The GC boxes centered at -313 (5'GC box) and -210 (3'GC box) bind Spl, and mutation at the 5' site results in significantly less functional activity. Surprisingly, Spl apparently acts as a repressor at the 3 'GC box. Review of the sequence immediately 3' to this site revealed a perfect AP2 consensus sequence, and it is possible that inhibition of Spl binding is permissive of AP2 activation. Other examples can be cited in which Spl exerts primarily repressor activity. Spl and the stage selector protein (SSP) compete for overlapping sites in the human y-globin gene promoter. In fetal erythroid cells, SSP activates the y-globin gene promoter, whereas in adult erythroid cells, Spl binding is enhanced, preventing SSP from binding and thus reducing expression of the y-globin gene (45) .
The third promoter element, the E box centered at -300, was protected from DNase I digestion in a continuous footprint with the 5 'GC box, but protein binding and transcriptional activation are independent of Spi. The bHLH protein binding to this E box is presumably MLTF/USF, since the anti-USF polyclonal antibody abolished DNA binding. It remains possible that other members of the bHLH family interact with this E box in vivo, or that MLTF/USF heterodimerizes with other bHLH proteins. MLTF/USF binding and transcriptional activation can be further regulated by methylation of the E box, with methylation having a negative effect (46) . This finding may have particular relevance to dCK, since lack of dCK gene expression in an cytosine arabinoside-resistant HL-60 cell line could be partially restored with the demethylating agent 5-azacytidine (47) .
The fourth promoter element, the E2F half-site, did not footprint well, and protein binding to this region could be detected only indirectly in a gel-shift assay. Nevertheless, DNase I digestion clearly revealed a hypersensitive site, and mutation within this site decreases promoter activity by -50%. Although E2F may play a role in basal dCK expression, there is no evidence to support the cell cycle-specific regulation of dCK transcription. Arner et al. have shown that dCK specific activity is constitutively high and does not increase by more than twofold during the cell cycle using resting and activated peripheral blood lymphocytes or elutriated CEM T lymphoblasts (15, 48 ( 19, 20) . Double mutations of the E2F sites in cellular genes abolish GI /S regulation either by preventing GI/ S induction (51) (52) (53) or by making the promoter constitutively active (54) (55) (56) (57) . When the DHFR dyad site is mutated to a halfsite, it still binds E2F and is activated by adenovirus ElA or human CMV immediate early proteins (33, 58) . However, when the human TK promoter is mutated so as to contain only a half-site, it binds E2F poorly, if at all, and GI IS induction is lost (59) . In the case of dCK and its half-site, the issue is not so much lack of Gl/S induction, but lack of repression during GO. We postulate that the lack of repression during GO is due 1666
Chen et al. phoresed, transferred to nylon, and sequentially hybridized to dCK cDNA and 28S rRNA oligonucleotide probes. Exposure times for dCK were several hours to overnight and under 60 min for 28S. (C) dCK enzyme activity in the various cell lines, measured using CdA as a substrate according to Arn& et al. (15) .
to the weak binding of E2F repressor complexes to the dCK half-site, but other members of the E2F family or associated proteins (60) not involved in cell cycle regulation may be important as positive factors for basal dCK promoter function. The question of why dCK and TK, two functionally similar enzymes in the deoxyribonucleoside salvage pathway, diverge in cell cycle expression is an interesting one; the difference may result from the presence of only one E2F half-site in the dCK promoter.
Although this study has resulted in the delineation of the basic elements regulating dCK transcription, the mechanism underlying high level thymic gene expression remains obscure. Elucidation of this mechanism will be important, since pharmacologic modulation of dCK expression could well play a role in enhancing the chemotherapeutic sensitivity of malignant cells to a number of nucleoside analogues. Future studies will be directed at elucidating the role of enhancer elements in dCK tissue-specific expression.
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